InBody Co.,Ltd (KOSDAQ:041830)
South Korea · Delayed Price · Currency is KRW 42,350
-1,000 (-2.31%)
May 21, 2026, 3:30 PM KST
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 578.21 billion as of May 20, 2026. Its market cap has increased by 94.25% in one year.
Market Cap
578.21B
Enterprise Value
451.72B
Revenue
233.95B
Ranking
n/a
PE Ratio
17.89
Stock Price
42,350.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 578.21B, an increase of 5,353.76%. That is a compound annual growth rate of 20.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 578.21B | 44.81% |
| Dec 30, 2025 | 399.30B | 34.21% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| L&C BIO Co.,LTD | 1.59T |
| Seegene | 1.43T |
| SEERS | 1.41T |
| WON TECH | 723.81B |
| ToolGen | 719.31B |
| Curexo | 557.01B |
| i-SENS | 516.75B |
| Bio Plus | 349.55B |